Experimental stem cell therapy aims to repair brain circuits in Parkinson’s A Phase 1 trial at Keck Medicine of USC is testing whether implanted iPSC-derived neurons can restore dopamine signaling and improve motor function.

https://www.drugdiscoverynews.com/experimental-stem-cell-therapy-aims-to-repair-brain-circuits-in-parkinson-s-17009 Parkinson’s disease (PD) is the fastest-growing neurodegenerative disorder worldwide, affecting an estimated one percent of individuals over the age of 60. In the US, more than one million people live with the disease, and roughly 90,000 new cases are diagnosed each year.